THE INTERACTION OF 5-FLUOROURACIL, HYDROXYUREA, AND RADIATION IN 2 HUMAN HEAD AND NECK-CANCER CELL-LINES

被引:0
|
作者
VOKES, EE [1 ]
BECKETT, M [1 ]
KARRISON, T [1 ]
WEICHSELBAUM, RR [1 ]
机构
[1] UNIV CHICAGO, MED CTR, DEPT RADIAT & CELLULAR ONCOL, CHICAGO, IL 60637 USA
关键词
5-FLUOROURACIL; HYDROXYUREA; RADIATION; HEAD NECK CANCER CELL LINES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the effects of 5-fluorouracil (5-FU) and hydroxyurea (HU) with radiation on two human head and neck squamous carcinoma cell lines. SQ-20B has a D0 of 239 cGy and an S phase fraction of 37%, while SQ-38 has a D0 of 146 cGy and an S phase fraction of 31%. For SQ-20B the surviving fraction at 100 cGy was significantly reduced (p < 0.05) when cells were exposed to HU or to 5-FU or both chemotherapy agents together with radiation. No significant effect was seen for SQ-38 with either chemotherapy agent alone or in combination with radiation as compared with radiation alone. Therefore, additive cytotoxicity between 5-FU and HU and radiotherapy was observed only in a head and neck cancer cell line with a higher DO and a higher S phase fraction.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 50 条
  • [1] TREATMENT OF RECURRENT HEAD AND NECK-CANCER WITH 5-FLUOROURACIL, HYDROXYUREA, AND REIRRADIATION
    WEPPELMANN, B
    WHEELER, RH
    PETERS, GE
    KIM, RY
    SPENCER, SA
    MEREDITH, RF
    SALTER, MM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 22 (05): : 1051 - 1056
  • [2] CONCOMITANT HYDROXYUREA, 5-FLUOROURACIL, AND RADIATION-THERAPY FOR RECURRENT HEAD AND NECK-CANCER - EARLY RESULTS
    VOKES, EE
    PANJE, WR
    WEICHSELBAUM, RR
    SCHILSKY, RL
    MORAN, WJ
    AWAN, AM
    GUARNIERI, CM
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1988, 98 (04) : 295 - 298
  • [3] METHOTREXATE AND 5-FLUOROURACIL IN HEAD AND NECK-CANCER
    RINGBORG, U
    EWERT, G
    KINNMAN, J
    LUNDQUIST, PG
    STRANDER, H
    SEMINARS IN ONCOLOGY, 1983, 10 (02) : 20 - 22
  • [4] CONCOMITANT CHEMORADIOTHERAPY WITH CISPLATIN, 5-FLUOROURACIL AND HYDROXYUREA IN POOR-PROGNOSIS HEAD AND NECK-CANCER
    HARAF, DJ
    VOKES, EE
    WEICHSELBAUM, RR
    PANJE, WR
    LARYNGOSCOPE, 1992, 102 (06): : 630 - 636
  • [5] COMPLICATIONS OF 5-FLUOROURACIL THERAPY IN HEAD AND NECK-CANCER PATIENTS
    HAMILL, NJ
    FREIJE, JE
    FEDOK, FG
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1995, 16 (01) : 74 - 77
  • [6] METHOTREXATE AND 5-FLUOROURACIL IN SEQUENCE IN SQUAMOUS HEAD AND NECK-CANCER
    PITMAN, SW
    KOWAL, CD
    BERTINO, JR
    SEMINARS IN ONCOLOGY, 1983, 10 (02) : 15 - 19
  • [7] NEOADJUVANT CHEMOTHERAPY WITH CARBOPLATIN 5-FLUOROURACIL IN HEAD AND NECK-CANCER
    DEPONDT, J
    GEHANNO, P
    MARTIN, M
    LELIEVRE, G
    GUERRIER, B
    PEYTRAL, C
    SCHOTT, H
    PELLAECOSSET, B
    ONCOLOGY, 1993, 50 : 23 - 27
  • [8] SURVIVAL AND ANALYSIS OF FAILURE FOLLOWING HYDROXYUREA, 5-FLUOROURACIL AND CONCOMITANT RADIATION-THERAPY IN POOR PROGNOSIS HEAD AND NECK-CANCER
    HARAF, DJ
    VOKES, EE
    PANJE, WR
    WEICHSELBAUM, RR
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (05): : 419 - 426
  • [9] Radiation therapy with 5-fluorouracil in head and neck cancer
    Fu, KK
    SEMINARS IN RADIATION ONCOLOGY, 1997, 7 (04) : 274 - 282
  • [10] NEOADJUVANT CHEMOTHERAPY WITH CISPLATINUM AND 5-FLUOROURACIL IN ADVANCED HEAD AND NECK-CANCER
    TEATINI, G
    MELONI, F
    BISAIL, M
    MILIA, V
    SANNA, G
    SAROBBA, MG
    MASSIDDA, B
    SCOTTO, T
    FARRIS, A
    JOURNAL OF CHEMOTHERAPY, 1990, 2 (06) : 394 - 396